NCT05225454

Brief Summary

Used multi-year health examination member profile by multi-algorithms technology, to find comprehensive key hazard factors or important high-risk group components for metabolic syndrome and chronic kidney disease or more common chronic diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
81,108

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 4, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2024

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2024

Completed
Last Updated

May 10, 2022

Status Verified

March 1, 2022

Enrollment Period

3.3 years

First QC Date

October 21, 2021

Last Update Submit

May 9, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with metabolic syndrome in kidney disease-related adverse events as assessed by estimated glomerular filtration rate

    Physiological information of participants with chronic kidney disease related adverse events as assessed in metabolic syndrome, by natural longitudinal change from baseline in estimated glomerular filtration rate at 2 years recent in health screening in participants.

    2 year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In 2006-2017 of the MJ Health Research Foundation's member, of the de-linked and de-identified annual health check database, about 71,108 people; 2015-2020, the Health2Sync provides \[Intelligent Anti-Glucose System\], the biometric and behavioral item de-linked and de-identified data, about 10,000 people.

You may qualify if:

  • Continuously health screening twice or more in MJ health reports.
  • Chronic kidney disease
  • Metabolic syndrome
  • Or more, common chronic diseases

You may not qualify if:

  • Participants who have received clinical treatment
  • Subjects of other related research diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oriental Institute of Technology / Far Eastern Memorial Hospital

New Taipei City, Pan-Chiao Dist., 22061, Taiwan

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicMetabolic SyndromeChronic Disease

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2021

First Posted

February 4, 2022

Study Start

March 3, 2021

Primary Completion

July 3, 2024

Study Completion

July 31, 2024

Last Updated

May 10, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations